Patent directory · USPTO A61K / A61P
Patents matching “modified”
433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12414963
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 12410209
Modified glucocorticoids
granted -
US 12402611
Genetically modified mice and engraftment
granted -
US 12385044
Modified double-stranded RNA agents
granted -
US 12385043
Modified double-stranded RNA agents
granted -
US 12378280
Deoxynucleic guanidines (DNG)-modified oligonucleotides and methods of synthesizing deoxynucleic guanidine strands
granted -
US 12378553
Modified double-stranded RNA agents
granted -
US 12331307
Modified immunization vectors
granted -
US 12331334
Modified urokinase-type plasminogen activator polypeptides and methods of use
granted -
US 12317874
Method of using a genetically modified mouse that expresses human albumin
granted -
US 12318418
Modified adenoviruses
granted -
US 12290573
Modified RNAi agents
granted -
US 12268688
Compositions and methods of use for modified release minoxidil
granted -
US 12269801
Modified amino acids
granted -
US 12252552
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
granted -
US 12250931
Genetically modified mouse with a humanized PNPLA3 gene and methods of use
granted -
US 12226403
Tebipenem pivoxil immediate and modified release oral dosage forms
granted -
US 12221622
Modified pluripotent cells
granted -
US 12215162
BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof
granted -
US 12203072
Chemically modified single-stranded rna-editing oligonucleotides
granted -
US 12173337
Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12168767
Modified double-stranded RNA agents
granted -
US 12161674
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
granted